The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
Evolent Health, Inc. pe ratio for the quarter ending 2026-06-30 was -1.21, a change of 8.93 year-over-year.
Evolent Health, Inc. pe ratio for the quarter ending 2026-03-31 was -0.51, a change of 9.62 year-over-year.
Evolent Health, Inc. pe ratio for the quarter ending 2025-12-31 was -0.83, a change of 20.45 year-over-year.
Evolent Health, Inc. pe ratio for the quarter ending 2025-09-30 was -7.74, a change of 37.79 year-over-year.
Evolent Health, Inc. pe ratio for fiscal 2026 was -1.21.
Evolent Health, Inc. pe ratio for fiscal 2025 was -0.83, a change of 20.45 from fiscal 2024.
Evolent Health, Inc. pe ratio for fiscal 2024 was -21.28, a change of 12.31 from fiscal 2023.
Evolent Health, Inc. pe ratio for fiscal 2023 was -33.59, a change of 114.68 from fiscal 2022.